Post Graduate Year 2 Solid Organ Transplant Resident
Location: Riyadh, Saudi Arabia
Solid Organ Transplant Pharmacy
About the program:
The PGY-2 solid organ transplant residency program was first established in 2013. The program is accredited by the American Society of Health-System Pharmacists® (ASHP) and Saudi Commission for Health Specialties. It remains the first and the only ASHP-accredited program outside the United States in Solid Organ Transplantation.
The program allows the resident to work with a wide variety of transplant patients, including liver, pancreas, kidney, lung, heart, intestinal, and multi-visceral transplants in both adult and pediatric populations. The learning experiences can be further tailored to match the resident's needs and interests.
PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education, and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residency in solid organ transplant provides residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 solid organ transplant pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification in the area of practice.
The program is 52 weeks long and includes 5 weeks of paid holiday or annual leave. It adopts a systematic approach to provide residents with opportunities and stimuli to develop skills, competencies, and professional expertise in all aspects of solid organ transplant pharmacy practices. The program comprises nine clinical learning experiences (seven required and two electives)— of five weeks each as well as an orientation. Elective learning experiences are available and should be developed based on the interests, goals, and career paths of the individual resident(s).
Required (core) learning experience: required or core is a mandatory learning experience for completing the residency program. Those will focus on the fundamentals of solid organ transplant knowledge and practice. Core learning experiences are designed to promote all required Competency Areas, Goals, and Objectives (CAGOs) of the residency program. In addition to the orientation learning experience, the resident will have seven core (5 weeks each) and five required longitudinal learning experiences.
Elective learning experience: The elective learning experience is designed to allow the resident to broaden and tailor their educational background, meet specific academic needs, or provide educational content that we recommend experienced by PGY-2 residents. It is also designed to enhance a particular interest. Over the year, residents must select three (two 5-week blocks and one longitudinal) LEs of electives. Electives can be chosen from any. Resident must select two from the elective rotations. When on electives, residents participate in ambulatory clinics, inpatient rounds, and conferences as appropriate to the rotation. Elective learning experiences will amalgamate the residency program's required and elective objectives. Other elective learning experiences may be developed based on resident interest and preceptor availability
Longitudinal learning experience: Longitudinal learning experience is up to 52-week long experience with time scheduled on a recurring basis. As residents gain clinical and scientific knowledge throughout the residency year, they become more adept at applying what they've learned to how they practice solid organ transplantation. It also enhances professional skills, like leadership, teamwork, and understanding transplant pharmacists' role at a systems level and how the resident can influence the given care. Longitudinal learning experiences will amalgamate between the required and elective objectives of the residency program.
PharmD degree from ACPE accredited College of Pharmacy.
All applicants MUST complete a General Pharmacy Practice residency from ASHP Accredited PGY-1 training program. o Residents under the auspice of SCFHS who are in their second-year training of the Clinical Pharmacy Diploma (i.e. PGY-1) are eligible to apply and to be interviewed. However, passing the final written exam of the SCFHS is essential for acceptance to the Saudi Specialty Certificate Programs in Pharmacy/PGY-2) depending on the final rank 4. All applicants MUST have valid SCFHS licensure at the time of the application. 5. The RPD will schedule an interview for applicants. 6. Residents must submit the following: o Three recommendation letters (of those, preferably one from PGY-1 RPD). We request a minimum of one (two is preferred) of your three references come from a preceptor who you have worked with in a clinical setting. All recommendation letters should be from clinical pharmacist consultants with at least one (two are preferred) to be from transplant clinical pharmacist. The clinical preceptor should be able to comment on your scope of responsibility, total patient load, ability to function independently, clinical abilities, and organizational and time management skills. All 3 reference writers should use the standard PhORCAS template to submit their candidate recommendation and comment on a minimum of 7 of the 13 listed candidate characteristics o Graduation certificate of Pharm.D. degree from ACPE accredited college of pharmacy (or one in process of pursuing accreditation) o Letter of intent o Active licensure at the KSA o Updated Curriculum vitae
Please visit Chief Executive Officer Message at :http://www.kfshrc.edu.sa/en/home/about/ceomessage
and Post graduate year 2 (PGY-2) Solid Organ Transplant Specialty Residency Program: https://www.kfshrc.edu.sa/en/home/edu/programs/postprogram/16091